- Home
- KPLT vs COYA Comparison
KPLT vs COYA Comparison
Compare KPLT & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KPLT
- COYA
- Stock Information
- Founded
- KPLT 2012
- COYA 2020
- Country
- KPLT United States
- COYA United States
- Employees
- KPLT 94
- COYA N/A
- Industry
- KPLT Diversified Commercial Services
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- KPLT Consumer Discretionary
- COYA Health Care
- Exchange
- KPLT Nasdaq
- COYA Nasdaq
- Market Cap
- KPLT 97.4M
- COYA 107.0M
- IPO Year
- KPLT N/A
- COYA 2022
- Fundamental
- Price
- KPLT $18.56
- COYA $6.09
- Analyst Decision
- KPLT Hold
- COYA Strong Buy
- Analyst Count
- KPLT 1
- COYA 4
- Target Price
- KPLT $10.00
- COYA $16.50
- AVG Volume (30 Days)
- KPLT 85.7K
- COYA 96.0K
- Earning Date
- KPLT 11-05-2025
- COYA 11-05-2025
- Dividend Yield
- KPLT N/A
- COYA N/A
- EPS Growth
- KPLT N/A
- COYA N/A
- EPS
- KPLT N/A
- COYA N/A
- Revenue
- KPLT $267,101,999.00
- COYA $423,452.00
- Revenue This Year
- KPLT $22.88
- COYA N/A
- Revenue Next Year
- KPLT $10.98
- COYA N/A
- P/E Ratio
- KPLT N/A
- COYA N/A
- Revenue Growth
- KPLT 13.04
- COYA N/A
- 52 Week Low
- KPLT $5.08
- COYA $4.65
- 52 Week High
- KPLT $24.34
- COYA $10.24
- Technical
- Relative Strength Index (RSI)
- KPLT 56.40
- COYA 44.51
- Support Level
- KPLT $13.25
- COYA $6.05
- Resistance Level
- KPLT $24.34
- COYA $6.53
- Average True Range (ATR)
- KPLT 2.19
- COYA 0.46
- MACD
- KPLT 0.13
- COYA -0.06
- Stochastic Oscillator
- KPLT 47.52
- COYA 8.96
About KPLT Katapult Holdings Inc.
Katapult Holdings Inc. is a technology-driven lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power the purchase of everyday durable goods for underserved U.S. non-prime consumers. It is an e-commerce-focused FinTech company offering a lease-purchase solution to consumers and enabling essential transactions at the merchant point of sale. Katapult is associated with hundreds of retailers across the United States.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.